text:
<?php
	session_start();

	include('processes/process.php');
	$connect = connectDB();

	$selectSY=mysqli_fetch_assoc(selectSY($connect));
	$datengayon = date('Y-m-d');
	$selectPenaltyValue=mysqli_fetch_assoc(selectPenaltyValue($connect));
	$percentage = $selectPenaltyValue['penalty']*(0.01);

	$_SESSION['studentfee'] = $_GET['id'];

	$checkStudent = viewStudentAccount($connect, $_GET['id']);
	$viewStudent = mysqli_fetch_assoc($checkStudent);

	if($viewStudent['student_id'] == null){
		echo "";
	}

	$getPenalty = getPenalty($connect, $_GET['id']);

				$duee=add('2011-01-30', 1);
	updateLastAccessed($connect, $datengayon, $_GET['id']);
	while($updatePenaltyRow = mysqli_fetch_assoc($getPenalty)){
		$x = 0;
		$due_date = $updatePenaltyRow['due_date'];
		if(strtotime($due_date) < strtotime($datengayon) && $due_date!=null && $updatePenaltyRow['waive'] == 0){
			echo $datengayon;
		while(strtotime($due_date) < strtotime($datengayon)){
			$x = $x+1;
			//$due_date = date("Y-m-d", strtotime("next month", strtotime($due_date)));
			$due_date1 = add($due_date, 1);
			//$due_date=add('2011-01-28', 1);
			//echo $due_date1->format('Y-m-d');
			$due_date = $due_date1->format('Y-m-d');
			//echo $due_date . "
";
			/*$time = strtotime("2010.12.11");
			$final = date("Y-m-d", strtotime("+1 month", $time))
*/		}
			$str = $due_date;
			//echo $str;
			$year = date('Y', strtotime($str));
			$month = date('m', strtotime($str));
			//echo $month;
			//echo $year;
			//echo date('Y-m-d', strtotime("$year-$month-30"));

			if(date('m', strtotime($str)) != 02 /*&& date('d', strtotime($str))==28*/){
				$due_date= date('Y-m-d', strtotime("$year-$month-30"));
			}
			$y = $updatePenaltyRow['penalty_count'] + $x;
		$penaltybalanceSum = (($updatePenaltyRow['balance'] * $percentage) * $x) + $updatePenaltyRow['penalty_balance'];
		updatePenalty($connect, $updatePenaltyRow['id'], $y, $penaltybalanceSum, $due_date);
		}
	}
		$sumBalance=mysqli_fetch_assoc(sumBalance($connect, $_GET['id']));
		updateTotalBalance($connect, $_GET['id'], $sumBalance['balance']);

		$getTotalBalance = getTotalBalancePrint($connect, $_GET['id'], $datengayon);
		$viewTotalBalance = mysqli_fetch_assoc($getTotalBalance);

	if(isset($_POST['submit'])){
		session_start();
		$_SESSION['studenttransac'] = 1;
		header('Location: payment.php');
	}
/*
	if(isset($_POST['delete'])){
		deleteStudent($connect, $_GET['id']);
		header('Location: studentaccounts.php');
	}
*/
	if(isset($_POST['edit'])){
		header('Location: editstudent.php?id='.$_GET['id']);
	}

	if(isset($_POST['restore'])){
		restoreStudent($connect, $_GET['id']);
		header('Location: viewstudent.php?id='.$_GET['id']);
	}

	if(isset($_POST['reenrol'])){
		header('Location: reenroll.php?id='.$_GET['id']);
	}
		if(isset($_POST['asd'])){
		extract($_POST);
		insertOtherRecords($connect, $_GET['id'], $grade_level, $quarter, $average);
		header('Location: viewstudent.php?id='.$_GET['id']);
	}

	if(isset($_POST['cancel'])){
		header('Location: viewstudent.php?id='.$_GET['id']);
	}

	if(isset($_POST['return'])){
		header('Location: viewstudent.php?id='.$_GET['id']);
	}
	if(isset($_POST['dsa'])){
		extract($_POST);
		insertAcademicStatus($connect, $_GET['id'], $grade_level, $quarter, $average);
		header('Location: viewstudent.php?id='.$_GET['id']);
	}

		$getAcademicStat = mysqli_fetch_assoc(getAcademicStat($connect, $_GET['id']));

	if(isset($_POST['sa'])){
		extract($_POST);
		updateAcademicStatus($connect, $_GET['id'], $grade_level, $quarter, $average);
		header('Location: viewstudent.php?id='.$_SESSION['studentfee']);
	}

	if(isset($_POST['da'])){
		deleteAcademicStatus($connect, $_GET['id']);
		header('Location: viewstudent.php?id='.$_SESSION['studentfee']);
	}

	if(isset($_POST['return'])){
		header('Location: viewstudent.php?id='.$_SESSION['studentfee']);
	}

$payment_date = date('Y-m-d');

	$mydate=getdate(date("U"));

	$checkStudent = viewStudentAccount($connect, $_SESSION['studentfee']);
	$viewStudent = mysqli_fetch_assoc($checkStudent);

	$checkARNumber = getARNumber($connect);
	$getARNumber = mysqli_fetch_assoc($checkARNumber);

    			/*if($balance['balance'] - $_POST['amount'] > 0 ){
    				echo '';
    			}*/

            	//$x = $x+$balance['balance'];
            	//echo $_POST['amount'];
			//echo $x . '
';
	if(isset($_POST['456'])){
		extract($_POST);
		$total=0;
		if(!empty($_POST['check_list'])) {

    		foreach($_POST['check_list'] as $check) {
				$balance = getBalance($connect, $check) -> fetch_assoc();
				$total = $total+$balance['balance']+$balance['penalty_balance'];
    		}
    		if($total >= $_POST['amount']){
    			$remaining = $_POST['amount'];
    			balancePayment($connect, $viewStudent['last_name'], $viewStudent['first_name'], $payment_date, $_POST['amount'], $_SESSION['studentfee'], $mydate['month'], $mydate['year'], $_POST['arnumber'], $_POST['dr'], $_POST['cr'], $remark, $viewStudent['grade'], $selectSY['from']." - ".$selectSY['to']);
    			foreach($_POST['check_list'] as $check) {
    					$balance = getBalance($connect, $check) -> fetch_assoc();
    					$remaining = ($balance['balance']) - $remaining;
    					if($remaining > 0){
    						balanceClear($connect, $check, $remaining);
    						break;
    					} else if ($remaining <= 0){
    						$remaining = (-1*$remaining);
    						balanceClear($connect, $check, 0);
    						$remaining = ($balance['penalty_balance']) - $remaining;
    						if($remaining > 0 ){
    							penaltyClear($connect, $check, $remaining);
    							break;
    						} else if($remaining <=0){
    							$remaining = (-1*$remaining);
    							penaltyClear($connect, $check, 0);
    						}
    					}
    			}
    		unset($_SESSION['studenttransac']);
    		header('Location: viewstudent.php?id='.$_GET['id']);
    		//header('Location: viewStudent.php?id='.$_SESSION['studentfee']);
    		}
		}
	}

$active = 0;
	?>

    <?php $header = "Student Info" ;?>
	<?php $header2 =  "Student General Information";

	include('header.php');?>

	<title><?php echo $viewStudent['first_name'] . " " . $viewStudent['last_name'];?></title>
			  <link href="asd/css/materialize.css" type="text/css" rel="stylesheet" media="screen,projection"/>
  <link href="asd/css/style.css" type="text/css" rel="stylesheet" media="screen,projection"/>
  <link href="asd/css/init.css" type="text/css" rel="stylesheet" media="screen,projection"/>

<form method="POST">

<?php if($_SESSION['access_control']>1){ ?>
<form method="POST">

<?php /*if($viewStudent['state']==0){ ?>

<button class="btn waves-effect waves-light green" type="submit" name="delete" value="Delete Student" style="position: relative;left: 0%;width:100%;" onclick="return confirm('Are you sure?');" >Delete Student</button>
<?php } else { ?>
<button class="btn waves-effect waves-light green" type="submit" name="restore" value="Restore Student" style="position: relative;left: 0%;width:100%;" onclick="return confirm('Are you sure?');" >Restore Student</button>

<?php } */?>

<button class=
<?php if($sumBalance['balance']>0){
	?>
"btn waves-effect waves-light white grey-text text-lighten-2 tooltipped"

<?php
 }

else{
?>
"btn waves-effect waves-light white blue-text text-lighten-2 tooltipped";
<?php
}

?>

data-position="top" data-delay="50"

data-tooltip=
<?php if($sumBalance['balance']>0){
	?>

	"Student has <?=$sumBalance['balance']?> remaining balance, All accounts must be settled for re-enrollment"

	<?php
}

else{
?>

	 "Re-enroll student";<?php
}

?>

 name=

 <?php if($sumBalance['balance']>0){
	?>

	"asd"

		<?php
}

else{
?>

	 "reenrol";<?php
}

?>

 value="Re-enroll Student" style="position: relative;; left: 0\5;width:100%;"  >Re-enroll Student</button>

<button class="btn waves-effect waves-light white blue-text text-lighten-2" type="submit" name="edit" value="Edit" style="position: relative;; left: 0%;width:100%;"  >Edit Student</button>

	</form>
<?php } else echo "

"?>
	<img class="backup_picture z-depth-1 " src="uploads/<?php if($viewstudent==null) echo "imagethumbnail"; else echo $_GET['id']; ?>" alt="Student Image" height="150" width="150" style="float:left;">

	First Name:
	<?=$viewStudent['first_name']?>
	Last Name:
	<?=$viewStudent['last_name']?>
	Middle Name:
	<?=$viewStudent['middle_name']?>

	Age:
	<?=$viewStudent['age']?>
	School Year:
	<?=$viewStudent['sy']?>
	Grade:
	<?=$viewStudent['grade']?>

	From:
	<?=$viewStudent['fromTime']?>
	To:
	<?=$viewStudent['toTime']?>

	Academic Status:
	<?=$viewStudent['academicstatus']?>

	Payment Mode:
	<?=$viewStudent['paymentmode']?>

Transactions

Academic Status

Other Records

Item
			Balance
			Due Date
			Penalty
			Penalty Count

  Actions

Pay

Print

<?php
	$table=getStudentBalance($connect, $_GET['id']);
	while($row=mysqli_fetch_assoc($table)){
?>
		<tr <?php if($_SESSION['access_control']>1){ ?> class="editBalance" <?php } ?> href="editbalan.php?id=<?=$row['id']?>">
			<?=$row['item']?>
			<?=$row['balance']?>
			<?=$row['due_date']?>
			<?=$row['penalty_balance']?>
			<?=$row['penalty_count']?>
			<?php if($row['waive']==0) echo ""; else echo "Waived";?>

<?php
	}
?>

		<form method="POST">
			<?=$viewStudent['first_name']?> <?=$viewStudent['last_name']?>

			Item
			Balance
			Due Date
			Penalty

<?php
	$table=getStudentBalancePayment($connect, $_GET['id']);
	$disablePayment=mysqli_fetch_assoc(disablePayment($connect, $_GET['id']));
	while($row=mysqli_fetch_assoc($table)){
?>

		<input type="checkbox"  name="check_list[]" value="<?=$row['id']?>" id="<?=$row['item']?>" <?php if($disablePayment['downpayment']>0&&$row['item']!='Downpayment') echo " disabled";?>/>
		  <label for="<?=$row['item']?>"><?=$row['item']?>

		<?=$row['balance']?>
			<?=$row['due_date']?>
			<?=$row['penalty_balance']?>

<?php
	}
?>

	<input type="number" min="0" placeholder="Enter Amount" name="amount"  pattern="[0-9]+([.][0-9]+)?" step="0.01" required/>
	<input type="number" min="0" placeholder="AR Number" name="arnumber" value="<?=$getARNumber['ar']+1?>" pattern="[0-9]+" required/>

	<input type="text" placeholder="Remarks" name="remark" required/>

	<button class="btn waves-effect waves-light white blue-text text-lighten-2" type="submit" name="456" value="Make Payment" >Make Payment</button>
	<button class="btn waves-effect waves-light white blue-text text-lighten-2" onclick="location.href='viewstudent.php?id=<?=$_GET['id'];?>'">Cancel</button>

</form>

Grade Level

Quarter

Average

 Add data

     <form method="POST">
	Grade Level<input type="text" name="grade_level" pattern="[0-9]+" required/>

	Quarter<input type="text" name="quarter" pattern="[A-Za-z0-9]+" requried/>

	Average<input type="text" name="average" pattern="[0-9]+" required/>

	<button class="btn waves-effect waves-light white blue-text text-lighten-2" type="submit" name="dsa" value="Save">Save</button>
	<button class="btn waves-effect waves-light white blue-text text-lighten-2" onclick="location.href='viewstudent.php?id=<?=$_GET['id'];?>'">Cancel</button>
</form>

<?php
	$table=getAcademicStatus($connect, $_GET['id']);
	while($row=mysqli_fetch_assoc($table)){
?>
		<tr class='editRowAS' href="editacademicstatus.php?id=<?=$row['id']?>">

			<?=$row['grade_level']?>
			 <?=$row['quarter']?>
			<?=$row['average']?>

<?php
	}
?>

	Date

	Sent To

	Reason

	Add data

      <form method="POST">
	Date<input type="date" name="grade_level" required/>

	Sent To<input type="text" name="quarter" pattern="[A-Za-z0-9]+" required/>

	Reason<input type="text" name="average" pattern="[A-Za-z0-9]+" required/>

	<button class="btn waves-effect waves-light white blue-text text-lighten-2" type="submit" name="asd" value="Save">Save</button>
	<button class="btn waves-effect waves-light white blue-text text-lighten-2" onclick="location.href='viewstudent.php?id=<?=$_GET['id'];?>'">Cancel</button>
</form>

<?php
	$table=getOtherRecords($connect, $_GET['id']);
	while($row=mysqli_fetch_assoc($table)){
?>
		<tr class='editRowOR' href="editotherrecords.php?id=<?=$row['id']?>">
			<?=$row['date']?>
			<?=$row['sent_to']?>
			<?=$row['reason']?>

<?php
	}

?>

</form>

<iframe id='fames' src="printsb.php?id=<?=$_GET['id']?>" name="frame">
<?php
	include('footer.php');
?>

redpajama_set_name: RedPajamaGithub


"Microcredit and willingness to pay for environmental quality: Evidence" by Ariel Ben Yishay, Andrew Fraker et al.
Low willingness to pay (WTP) for environmental quality in developing countries is a key research question in environmental economics. One explanation is that missing credit markets may suppress WTP for environmental improvements that require large up-front investments. We test the impact of microloans on WTP for hygienic latrines via a randomized controlled trial in 30 villages in rural Cambodia. We find that microcredit dramatically raises WTP for improved latrines, with 60% of households in the Financing arm willing to purchase at an unsubsidized price, relative to 25% in the Non-financing arm. Effects on latrine installation are positive but muted by several factors, including a negative peer effect: randomly induced purchases by neighbors reduce a household's probability of installing its own latrine. On methodological grounds, this paper shows that a "decision-focused evaluation" can be integrated into academic analysis to provide insight into questions of general interest. (C) 2017 The Authors. Published by Elsevier Inc.
Ben Yishay, Ariel; Fraker, Andrew; Guiteras, Raymond; Palloni, Giordano; Shah, Neil Buddy; Shirrell, Stuart; and Wang, Paul, Microcredit and willingness to pay for environmental quality: Evidence from a randomized-controlled trial of finance for sanitation in rural Cambodia (2017). JOURNAL OF ENVIRONMENTAL ECONOMICS AND MANAGEMENT, 86.


I am sharing my ideas on Twitter, Linkedin, YouTube, Google+ and Facebook. You can contact me using one of these platforms.
However, the quickest way to get feedback is to send me an e-mail: mail@sandervanvugt.nl.


text:
In English classes around the world, in countries where English is a second (or third, fourth, etc.) language, the word "hubbub" was often ignored. Therefore, 14 years ago a group of us decided that this situation needed to be addressed. We sent letters and petitions to all major and minor publishers of English as a second language textbooks. In addition, we sent delegations to visit countless ESL master programs at universities, as well as private international English schools for all ages. We have delivered lectures in classrooms and hallways and have distributed brochures and buttons. The buttons are our most popular weapon. In a variety of arresting background colors our word blares, barks, beeps, breathes, blasts, blurts, brays, bellows, and bears witness. We have seen a steady increase of appreciation of our word's significance. If all continues to go as planned, by 2060 we will disband our organization, having achieved every one of our 17 goals.
Stray Thought About Hitler
When I lived in a Greek village for two years
there were times when I'd see smashed turtles
on paved roads, big turtles, and I couldn't help thinking
a few drivers aimed for them. If I'd see a live one
I'd pull off to the side, lift the turtle to where it
seemed to be heading. It occurred to me just now
that perhaps Hitler, driving, seeing one, wouldn't have aimed
his car at it (if he did drive), not wanting to think himself
heartless. Perhaps he, too, might even stop and
carry it to safety, especially if he had a witness along.
I haven't studied him enough to know what he thought of himself.
I should, I just keep putting it off.
Enter, Tain
My friend writes that she wants her poems to entertain. I never think of it that way. Though I like the enter, I don't know what to do with tain. Entering somewhere unknown, that's what I try to do. I remember a day with my best friend in high school. Which of us was driving? We stopped at a home under construction, but deserted. Trespassed. Didn't vandalize or steal. Went in through the missing front door. An expensive home, a spiral staircase leading to unfinished rooms. Everything was unfinished. My poet friend says she likes snug prose poems, no more than 200 words. I'm halfway to 200, or was. Was halfway to almost everything in this paragraph, though half is a generous assessment. Entertainment, who reads for boredom? My high school friend and I were never caught, until now. I won't name him. The Statute of Limitations for misdemeanors revealed in poems, in Arizona, hasn't been written yet. Legislators should craft it so that it comes in at 199 words. That will take them years, condensing and arguing, deleting and calling each other names their mothers never gave them. Tain drifts away, it never entered.
Broken Trees in Our Yard
The long drought, then harsh winds
snapped big branches of mesquites,
that have stood intact for the 33 years
we've lived here. Smaller lives
knocked over, various
cactuses, dead. This is literally breaking
news. La la la sounds like a song
but a single la begins lament.
Some of the biggest broken
branches have enough connection
that the leaves have remained green
and I'm not going to saw them down.
One, still attached, provides shadow
to a young saguaro. I won't remove that
either. But now walking around the yard
has changed a little, more reminders
of fate. Someone just posted a YouTube video
of a poet who died
reading a poem that, at its beginning
is about dying. He is reading
outside, in Ireland it seems, green
moving leaves behind him and birds,
lots of birds whose songs we hear
with his voice. Derek Mahon, reading
"Everything Is Going To Be Alright."
Purple irises, also
known as the blue flag, the northern
blue flag, are easy to grow. My mother's father
grew them in Minneapolis and my mother
brought the seeds to Phoenix, to remember
her father when they came up, a flag for him
and for her childhood, all her years. Purple, though
some say blue, they grew in the Phoenix shade
next to a wall. She didn't bring them in, the way my father
brought his roses, every year, into our home. And
after she died none of her three sons raised those
irises in our yards. We never brought them in
to our lives, as she did. They're my mirage.
Poem for My Older Brother
Ed is 71 now, I'm 69. When we were growing up together, at 5832 North Second Avenue, in Phoenix, I never imagined what it would be like to be this old. I haven't asked him if he did. But today I phoned him and asked him to give me two words and said I'd try to write a poem using them. He said, "stork and newspaper."
I step outside, into our desert backyard (I'm in Tucson, he's in Montclair, New Jersey). I'm out in the sun for a minute and my cell phone rings.
"If it's not too late, I'd like to change newspaper to BarcaLounger."
Every time I think of a stork I recall a fourth grade classroom at Madison Meadows in Phoenix. There was a dark-haired short girl sitting in a middle row of desks, in a middle desk, and it must've been before class, before the teacher entered. A boy walked over to her and announced to the rest of us that this girl believed that storks deliver babies. Some kids laughed. I didn't. I'd never believed storks delivered babies, my parents hadn't told me that and I don't recall ever asking them where babies came from. I was sitting near the back of the class, as usual. I felt terrible for the girl, but didn't say anything. She wasn't someone I talked to. It was my first year at the school, I didn't know most of the other kids very well. But I wish, now, I'd stood up for her.
In dumps around the world there are discarded BarcaLoungers that storks have landed upon. I like to think of a stork's white being in contrast to the dark upholstery, while the black of the stork's feathers blend in from a distance.
Several thousand white storks in Spain and Portugal have stopped migrating to Africa and, instead, gather in landfills. They have been able to raise more chicks than they could if they'd flown to Africa. Think, Ed, of stork chicks in a nest on a BarcaLounger. Both parents feed the chicks, taking turns. They never would've landed in this paragraph, or the paragraph above, if you hadn't called me back.
John Levy's books of poetry include Among the Consonants (The Elizabeth Press, 1980), Oblivion, Tyrants, Crumbs (First Intensity Press, 2008), and Silence Like Another Name (otata's bookshelf, 2019). He is a retired county public defender.
posted by mark young at 11:33 AM

redpajama_set_name: RedPajamaCommonCrawl


text:
International Board of Advisors
JGU at a Glance
Learn about the world-class humanities education offered at JSLH.
B.A. (Hons.) Liberal Arts And Humanities
Learn about our Liberal Arts and Humanities Graduate programme.
NRI and International Admissions
Jindal Scholastic Aptitude Test (JSAT)
Login to your application page to reserve your place in the class
of 2020.
Faculty Articles
Curriculum & Pedagogy
JGU is a research-driven university fostering excellence in teaching, research, and community service.
Faculty & Research Overview
AVINASH A. GODBOLE>
Avinash A. Godbole
B.A. (Psychology) (University of Mumbai); M.A.; M.Phil.; Ph.D. (School of International Studies, Jawaharlal Nehru University)
agodbole@jgu.edu.in
Dr. Avinash A. Godbole was a Research Fellow at the Indian Council of World Affairs from March 2016 to January 2018. Before that, he was Research Assistant at IDSA. He was awarded Doctor of Philosophy at School of International Studies, Jawaharlal Nehru University in January 2016. His doctoral thesis is on the Political Economy of China's Environment. He was a Visiting Fox Fellow at the Macmillan Center at Yale in 2007-08. His research interests are in the fields of Chinese Foreign Policy, Environmental Changes in China, Minorities in China, Domestic Politics in China, China's Asia strategy and India-China Relations. He has written extensively on these subjects in academic and media publications.
Student Hand book
JSAT – India Admission Test
Programme Brochure
Jindal School of Liberal Arts & Humanities
O.P. Jindal Global University
Sonipat, Narela Road
Near Jagdishpur village Sonipat,
Haryana-131001, NCR of Delhi, India.
: admissions.jslh@jgu.edu.in


Montserrat Oliver, Kate Del Castillo, Yolanda Andrade and the rest of "Las Lagartonas," name they decided to use to refer to their close group of friends, recently celebrated 20 years of friendship. When Del Castillo manages to make a quick trip to Mexico City, a friend reunion in one of their homes is mandatory, as we can tell from their Instagram accounts.
None of Kate's friends agreed to talk about her relationship with Joaquín "El Chapo" Guzmán after Rolling Stone magazine published Sean Penn's article, in which he names Kate as his facilitator for the meeting with the Sinaloa Cartel leader. But in a recent interview published by The New Yorker, Oliver speaks her mind about her good friend, and her decision to move forward with this project.
The Mexican government has constantly failed to publicly specify what exactly Del Castillo is being investigated for, or if they have any viable charges against her. Her father, Eric Del Castillo, told the media earlier this week that his daughter is willing to cooperate with the authorities, but she hasn't been called to share her testimony.


text:
St Peter's Parish, Surry Hills
Home > Who We Are
St Peter's is blessed with an abundance of friendly, diligent and committed parishioners who regularly attend 10:30am Sunday Mass and take an active part in the variety of activities that occur after Mass and during the week. Co-ordinated by Fr. John Macdonald, the parish enjoys the luxury of a 16-strong choir, which rehearses on Monday evenings, conducted by Gerard Horsfall. After 10:30am Mass, refreshments on a Sunday are put together by the Parish volunteers, who also actively participate in the Evangelium program which is run for the young adults after refreshments. Whilst having a number of older parishioners, the parish is also blessed to have families with young children, who play a variety of games and sports after Mass, building the future community of the parish.
St Peter's is blessed to have a good number of young single adults who strive to live their faith in a vibrant and committed fashion. Because of the closeness of the community, St Peter's has also been able to internationalise itself by sending members of the parish to places like Spain and Papua New Guinea, the latter being a trip organised by Fr Bill for the St Peter's Choir to Mt Hagen to teach sacred music to the local population in preparation for the new cathedral designed by architect and parishioner John O'Brien.
235 Devonshire Street
(near Crown St)
Email: st61538@bigpond.net.au
Administrator: Rev John Macdonald Adm
Faithful mark Eileen's centenary
Padre in Paris: Fr Josh's Mission trip to France
Simcha Fisher: The fairy tale of America
Euthanasia focus would be 'tone deaf'
© 2018 Copyright: St. Peters Catholic Parish, Surry Hills


text:
Chris Hemsworth Joins Kristen Wiig and Melissa McCarthy in Female Ghostbusters
Who you gonna call? Thor, apparently.
By Julie Miller
By Jason Merritt/Getty Images.
Paul Feig has just announced a delightful new addition to his Ghostbusters reboot cast: Chris Hemsworth. And according to the director, Thor will take his baddie-busting heroics down a notch, to play a supporting part alongside the film's quartet of leading females Kristen Wiig, Melissa McCarthy, Kate McKinnon, and Leslie Jones. Here's Feig's announcement:
https://twitter.com/paulfeig/status/608780626595037184
Variety reports behind-the-scenes details about the casting coup:
Insiders say the studio went to Hemsworth very early on in the process for one of the major male roles but the Aussie actor passed because the role was too small. Since then Sony sent the script back to be reworked so the part could be beefed up.
Known more for his action-heavy role like Thor, Snow White and the Huntsman, and the upcoming In the Heart of the Sea, Hemsworth is said to be wanting to broaden his brand and get into more comedies starting with his juicy role in the upcoming "Vacation" reboot, which opens this July.
The Feig-directed film is being produced by original Ghostbusters director Ivan Reitman, and is scheduled to open in theaters on July 22, 2016.
An Investigation of Intimacy: Brigitte Lacombe's Astounding Celebrity Portraits
Photograph by Brigitte Lacombe.
Meryl Streep, New York, N.Y. 1988.
Julie Miller is a senior feature writer at Vanity Fair.


You may well recognise this bike from the Grand Tours this summer. Cadel Evans rode this frame design, decked out in Ridley stickers, during the time trial stages in the Tour de France.
It comes from a mould in a carbon factory in China. Planet X developed the frame design but because it didn?t buy the mould itself, other manufacturers can also jump in, hence its appearance at the Tour.
With a striking appearance and aggressive tubing shapes, which all are triangulated, the Stealth is certainly solid under power thanks to the large junction designed around the bottom bracket and chainstays.
A miniscule head tube allows anyone with the skills of a contortionist to get as low as they like, which is a nice option.
the above two frames alone.
The horizontal lines along the top tube and profiled stays aim to give the Stealth aero qualities of the bigger players without an exclusive price tag. On the downside we found that the handlebar extensions weren?t that sturdy. With an option to upgrade to deeper section wheels our 101 rear and 82 front wheels did the job. Considering their price, these tubular carbon wheels do an excellent job.
When you combine a solid performance with Shimano Dura-Ace, it?s hard to fault the Stealth.


text:
PFIZER's 23% SURGE IN DECEMBER CAPS BIG YEAR; DRUG STOCKS ARE WINNERS ACROSS-THE-BOARD; FUTURE PRICE RESTRAINTS ARE GAINING WALL STREET ATTENTION
Pfizer is "Z" most attractive of the financial community's pharmaceutical darlings as the new trading year begins. The company's dramatic 23% surge in market valuation during the last month of 1991 stock trading marks it as a stand-out in a stand-out sector. The company's two fourth-quarter approvals for a pair of "Z"- branded products -- Zithromax (azithromycin) and Zoloft (sertraline) -- added renewed vigor to a year-long upward ride for the stock. For the full-year, the company's stock doubled in value: beginning the year at 80-3/4; splitting two-for-one at the end of the first quarter; and then climbing back again to close 1991 at 81-3/4. Pfizer was one of 13 stocks in the F-D-C Index to show a gain in 1991 trading of 100% or greater over its 1990 close. The 30- issue Pharmaceutical Component posted a 52.4% increase -- its second best performance in the 30 years that F-D-C Reports has maintained indices tracking pharmaceutical stock performance. In 1985, the Pharmaceutical Component advanced more than 53%. In a year in which the two hottest sectors of the U.S. economy arguably were health care and the stock market, the NYSE/AMEX- traded pharmaceutical companies were perfectly positioned for broad investment interest. The 52.4% jump by the F-D-C pharmaceutical group compares to a 20.3% gain by the Dow and a 26.2% bound by the S&P 500. FDA's approval pace helped also. The agency approved 30 new chemical entities during the year -- with less than a third of the approvals coming in the traditional end-of-the-year wave. The FDA approvals were not heavily skewed toward low-market potential products: a number of products, such as Abbott's Biaxin, Lilly's Lorabid, Marion Merrell Dow's Seldane-D and Merck's Zocor, give major marketing companies new entries to categories in which they already have a sizeable presence but could use new product support. The FDA was viewed generally as a tough enforcement adversary in industry circles during 1991 because of the crackdowns on alleged promotion violations. But the FDA under Commissioner Kessler is not a one-dimensional agency. It is playing to both sides of its mission statement, enough so on the approval side that the investment community appears to project reasonable approval paths for pipeline products. The rush to pharmaceutical and pharmaceutical-related stocks stretched from the largest of the established firms to the more speculative companies: Merck and Glaxo were each up over 85%; Bolar was up 465% and ICN jumped 526%. Among the few major firms to be left behind by the upswing were the two leading U.S. drug wholesalers. McKesson was up 7.4% on a 2-1/2 point gain to 36-1/2 and Bergen-Brunswig was off 19% to close at 22-7/8. Also lagging behind the crowd in 1991 were Lilly (up 14% on a 10-1/4 gain) and Marion Merrell Dow (flat at 36-3/8). While their own stock performances were mediocre, they are interesting examples of a new phenomenon in pharmaceutical investing. Both Lilly and Marion Merrell Dow (MMD) had the odd, but noteworthy, distinction of having investment porfolios made up of stakes in other drug companies that outperformed the growth of their own stocks in terms of percentage increases. MMD, for example, has equity investments in at least four publicly-traded start-up companies. These positions, purchased for a total of $47.5 mil., had already shown good appreciation by the start of 1991, carrying a valuation of $83.3 mil. at that point. By the end of the year, those holdings had more than quadrupled in value, closing 1991 at $356.7 mil. Similarly, Lilly's investments in five public companies, purchased for a total of $20.3 mil. and valued at $19.8 mil. at the start of the year, closed the year worth $40.5 mil., a 104% increase. The eye-catching performances of the MMD and Lilly portfolios reflect both the 1991 run-up in biotech stocks and, more interestingly, the increasing role of major drug companies as investment firms in the drug business as well as their more traditional roles as R&D, marketing and production companies. The investments in start-ups by larger firms are primarily aimed at gaining a tie-in to a particular research or product development area, but a new side benefit is developing in the short-term appreciation of stock positions. The run-up in 1991 presents companies like Lilly and MMD with the possibility of a substantial short-term payoff from agreements with R&D firms years before the deals yield marketable products. While companies may be unlikely to cash out their investments in small start-ups during an active collaboration, the past year provides a precedent for the realization by an established firm of a significant return on a biotech investment. In February, Abbott liquidated its Amgen holdings and returned over $200 mil. on an initial investment of $5 mil. ("The Pink Sheet" Feb. 18, T&G-11). Abbott did not receive any products from the Amgen deal. The big growth for MMD's portfolio in 1991 was triggered by the company's 19.6% (2.5 mil. share) interest in U.S. Bioscience. Like the Abbott investment in Amgen, that investment is not directly attached to any product objectives. MMD's U.S. Bioscience stake quadrupled in value during the year; the cancer chemotherapy company was one of the stars on the F-D-C Index. From an opening price of 19-1/2, U.S. Bioscience shares soared to 78, a whopping 300% increase. At the end of the year, U.S. Bioscience carried a market valuation of $1.5 bil. (only slightly less than the $1.58 bil. valuation carried by the 30-year-old Mylan generic drugs business). The financial community did not reflect U.S. Bioscience's glamor back onto the major investor, but at least one major Swiss company, Sandoz, appeared willing to bet that its investments could help create a new image for the firm on Wall Street. Sandoz embarked on an apparent strategy of using sizeable investments in U.S. start-ups as a way to draw investment attention to itself -- and thus increase its own potential to raise money from the public markets. Beginning with the announcement of a $1 bil. "Innovascan" biotechnology discovery initiative in February, the Swiss company was an active investor during 1991. After a series of small deals, the Swiss company capped the year with the Dec. 16 purchase of 60% of SyStemix for $392 mil. The Swiss company has been taking the first steps towards making itself a more publicly-oriented firm outside its home country. In a presentation to U.S. analysts in early November, the firm explained that it perceives a need for new sources of capital from outside Switzerland. Sandoz ADRs (American depositary receipts) began trading in the U.S. on Nov. 7. If Sandoz can build on the attention that it garnered from the SyStemix deal and parlay that attention into a following on Wall Street, it may have increased access to the public markets outside Switzerland. The scientific and commercial prospects of SyStemix aside, Sandoz may be able to ride that deal into a period of greater equity funding. Whether as investors or investments, the drug companies were hot in 1991 and particularly hot during the general December market rally. The pharmaceutical industry enters 1992 with numerous positive ratings from general investment surveys. The ValueLine survey, for example, rates the drug industry No. 1 out of 98 industries covered by rank of probable performance over the next 12 months. Among the high expectations for drug stocks, some of the loftiest have been set for Pfizer and U.S. Bioscience. In its year-end issue, Financial World magazine reflects the current enthusiasm for Pfizer by placing the company into competition with Merck for the preeminent position in the industry. "Pfizer...has long vied to unseat Merck as the industry's leading manufacturer," the financial magazine states. "Many analysts," the financial trade publication maintains, "say Pfizer's long-term growth potential is better." The financial community is estimating short-term earnings per share growth for Pfizer and Merck (through 1992) at about 18%. Zoloft, Pfizer's entry into the antidepressant category, is one of the products behind the new high. Zoloft will come into the market as the second serotonin-reuptake inhibitor in the wake of Lilly's Prozac brand. While Zoloft will carry much the same labeling language as Prozac (especially in regards to suicidal ideation), the appearance of a second product without the wide publicity of Prozac may have a strong appeal to prescribing physicians. Alex. Brown's Adele Haley maintains that the Pfizer product may have a pharmacokinetic profile advantage over Prozac. FDA's approved labeling for Zoloft says that the product has a terminal half-life elimination of about 26 hours and steady state plasma levels can be reached with about one week of once-daily dosing. Prozac has a longer half-life (2 to 3 days for the active ingredient fluoxetine) and "steady state concentrations are only achieved after continuous dosing for weeks," the Lilly drug's labeling states. Combined first-year sales predictions for Zoloft and Zithromax run in the range of $300 mil. and should offset the anticipated decline in Feldene (piroxicam) sales when that product loses exclusive marketing protection in early April of this year. Between the shift from Procardia to Procardia XL in 1989-1990 and the introduction of a new group of products to coincide with the expiration of protections on Feldene, Pfizer appears to have made a significant product generation shift without missing a beat. Procardia XL may face a me-too challenge from K-V (up 295% to 33- 1/8) which received an okay from FDA, in the fall, to file an ANDA for a different form of extended-release nifedipine capsule. The antifungal Diflucan (estimated at about $380 mil. in sales in 1991) and the alpha-blocker Cardura (estimated in excess of $100 mil.) also are providing substantial new sources of drug growth for Pfizer. Further new product excitement for 1992 centers on three products: Norvasc (amlodipine), a calcium channel blocker which has already been recommended for approval by an advisory committee at FDA; Reactine (cetirizine), a non-sedating antihistamine; and E5, the Xoma monoclonal for sepsis. Like Pfizer, U.S. Bioscience is entering 1992 riding a wave of late market momentum. The firm had a 26% gain in the first two weeks of December trading and finished the year at 78, up 28% for the final month. At the year's end, the company announced a two- for-one stock split, effective in mid-January. U.S. Bioscience began 1991 with the launch of its first product, Hexalen, for the treatment of ovarian cancer. While estimated 1991 sales of about $3.5 mil. are not enough to make the company profitable, Hexalen helped differentiate U.S. Bioscience from other start-ups by giving the company a tangible regulatory success and an established medical and marketing presence. When the company completed a secondary offering in May, its shares had climbed to the low-30's. The Oct. 1 filing of an NDA for U.S. Bioscience's second product, the chemoprotective agent Ethyol, drove the stock into the 40's. Analysts were impressed by U.S. Bioscience's handling of the 20-year-old drug, licensed from the U.S. Army in 1988, and projected sales (for both chemo- and radioprotective indications) of $350-$500 mil. per year at maturity. The smoldering interest in the company caught fire on Nov. 17, when President Philip Schein, MD, told the Robertson Stephens annual healthcare conference that FDA's Oncologic Drugs Advisory Committee would review the drug at its Jan. 31 meeting. Investors celebrated the rapid movement of the product to an advisory committee as a sign of an accelerating development schedule for the product and an increased chance for it to lead the company to profitability. The stock, which had slumped to 36- 3/4 as part of a biotech sell-off the week before, added 15 points (and over $350 mil. in market valuation) during the week of the 17th. U.S. Bioscience was suddenly valued at over $1 bil. and thrust into the spotlight. The stock flourished with the attention. Investors attracted by the Ethyol announcement also saw a pipeline with other possible near-term product opportunities, including trimetrexate for AIDS-related pneumonias and PALA, AZQ, and rogletimide for cancer indications. Investors also reacted positively to the company's November overseas licensing deals with Schering-Plough (for several products, including Hexalen and Ethyol) and with Rhone-Poulenc Rorer (for Hexalen). Alex. Brown's David Webber summarized the market's reaction to the Ethyol announcement. The scheduling of the advisory committee and the announcement of the licensing agreements "broadly validates the U.S. Bioscience investment thesis and reflects in a masterly fashion the maturing of the U.S. Bioscience strategy" of licensing oncology products already in the clinic. Webber forecast a third quarter 1992 approval for Ethyol and estimated that its sales would make U.S. Bioscience profitable for the year. Webber also projected that an NDA for trimetrexate would be filed in January, with expedited approval by year-end. The Alex. Brown analyst forecast a 6-12 month share price of $100 for the company. Some of the threats to Pfizer and U.S. Bioscience are interesting as examples of the dark side to the gilded prospects for the industry. One pressing issue at Pfizer is the delay in the marketing of Zithromax. The company said at the end of the year that it is "voluntarily" withholding introduction of the product until FDA can review information on 19 adverse events omitted in submissions to FDA. The delay is dangerous to Pfizer for two reasons: (1) there are three new antibiotics, in addition to azithromycin, ready to enter the market; and (2) the suggestion of withheld information may stimulate the attention of previous critics of Pfizer's regulatory dealings. Pfizer has grappled several times in the past with the Public Citizen Health Research Group over Feldene and the Shiley heart valve. The fights are messy public relations events that often spill over into the congressional arena and the courts. A second threat facing Pfizer, U.S. Biosciences and the rest of the industry is the continued attention to pharmaceutical pricing. U.S. Bioscience faces the most troublesome aspects of pricing with its product Ethyol: how to explain and justify the high-cost of a product licensed from the U.S. government. The estimated per treatment price for Ethyol is being projected in the $2,000 range. While much of the political attention on drug pricing is being focused on the established drug companies and their existing products, more concern in the marketplace appears to be directed to the new biotech products and to the replacement generations for traditional drug products. The pre-approval preparations for the anti-sepsis monoclonals (Centocor's Centoxin and the Pfizer/Xoma E5) are an extreme example of the current cost awareness among hospitals. Hospital pharmacies are projecting that the anti-sepsis products could represent between 10-20% of an average hospital's annual drug budget in one year. Prominent hospital groups are getting together prior to the anti-sepsis approvals to determine treatment guidelines ("The Pink Sheet" Dec. 23, p. 14). Politicians, however, are missing the thrust of that marketplace concern and remain locked on the issue of yearly increases in old product prices. It now appears as a truism that most drug prices are increasing at above inflation rates. The extent to which that argument is accepted was reflected by Sen. Hatch's (R-Utah) remarks in early December to the annual Food & Drug Law Institute meeting ("The Pink Sheet" Dec. 16, p. 8). Hatch, who often represents the brandname industry's views on Capitol Hill, declared that recent information brought to the attention of his staff appear "to validate the criticism that PMA companies are not pricing their products appropriately after patent expiration in what should be a competitive market place." In contrast to the drug pricing image in Washington and in the general media, there is a recognition in the trade that pricing patterns have already changed. For more than six months, major wholesalers have been openly commenting on the slowdown in price increases and what that slowdown will do to their profit potential. In an early November interview between Robert Walter, the chairman of Cardinal Distributors, and an analyst from Smith Barney, the wholesaler said: "Price increases have moderated, and we are assuming that these increases will remain 1-2 percentage points less than the increases during recent years of about 7-8% annually." Hatch's remarks in December illustrate the frustration he felt about failing to get a resolution on the size and extent of industry rebates to government programs at the end of the last legislative session. He noted that the issue remains on the Capitol Hill agenda for 1992. His pessimistic tone on the outcome of the renewed debate and his predictions that industry critics may take the initiative are filtering into some public prognostications on the industry. Indicative of the wide currency of the concerns about price restraints, a Reuters financial service wrap-up piece on 1991 tempers the good financial news for the drug industry in the past year with a prediction that the industry may "face a tougher 1992 because they may have to swallow the bitter pill of government price regulation." The fact that the Capitol Hill debate still focuses on prices of old products may be a blessing in disguise for the industry. As long as the political debate remains centered on the pricing patterns for existing products, the long-term effect can be ameliorated by the R&D pipelines and relatively unfettered "access" for new products. The more serious attack will evolve from any attempts to determine price limits for new products. While that type of attack sounds far-fetched, that is exactly the type of issue behind such public debates as pricing for Retrovir, and it appears to be emerging as the new theme for the high-price biotech items. Bristol-Myers Squibb carefully dodged a potential pricing issue late in the summer when the company introduced Videx (ddI) at a price calculated to fall just below the annual cost of Retrovir. The Videx pricing indicated a long-term view of the company's drug portfolio, protecting the taxol cancer drug development project. BMS is working with a government license and government harvest rights on that project. A flap over misuse of an NIH- licensed drug in the AIDS field might have raised significant problems for the cancer project. The Videx pricing also fit the new trend emerging in the industry for follow-up compounds. The days of the premium price for the subsequent compounds in a class seem to have passed quietly. BMS had a big year at FDA with four approvals for new chemical entities (Videx, Pravachol, Monopril and Cefzil) and at least one interesting new formulation product (Stadol NS), which could be positioned for any increase in the awareness of migraine treatment. BMS trailed the index average in increase, however, up 32% for the year. With Pravachol, BMS joins Merck and Warner-Lambert as a major force in the lipid-lowering field. BMS is projecting a huge increase in the potential patient population for lipid treatment. With an NIH Consensus Conference coming up on the topic in February and a new set of treatment levels to be issued by another NIH institute later this year, the possibility for rapid market expansion appears likely. Merck's Zocor approval and the co- marketing agreement with SmithKline Beecham assure that there will be a lot of noise in the cholesterol/lipid treatment field in 1992. Abbott had two approvals in 1991: the antibiotic Biaxin and an orphan drug, the surfactuant Survanta. Biaxin excites some analysts as a way for Abbott to trade up its $120 mil. U.S. erythromycin market to the higher price product. With the "coming soon" approval for Omniflox (temafloxacin), analysts hope that Abbott can revive its antibiotic business. Abbott's attempt to pull off the trade-up should be a noteworthy test of price resistance in the new market conditions. Biaxin, with a better gastrointestinal effects profile than standard erythromycin, is priced at about $5.00 per day compared to $.80-$1.00 per day for its current erythromycin products. Abbott's breadth across the health care business earned it a profile piece in the Frobes financial review of 1991. Its 53% gain in 1991 trading on top of a 32% gain the year before make a good backdrop for financial magazine features. J&J (up 42-3/4 points, almost 60% for the year) is also getting more lively coverage for its drug business, after the very successful approval year in 1990. With a rare Dec. 6 investor seminar, the company is cultivating some of that attention more actively. At least one analyst came away dazzled. Shearson Lehman's Mimi Willard enthusiastically issued a post-meeting report declaring that J&J "left people with a clear impression that it has the potential to accelerate its EPS growth rate fromthe past five years' 18%." Willard, a strong proponent of J&J's opportunities as the other EPO company, noted that the firm did not report much on its progress with that product. That fits the current situation of extensive off-label use of for the J&J brand Procrit. It would be risky for J&J to play up the success of the product. The extent of that success was indicated recently when one major Texas cancer center reported using $60,000 per month of J&J's EPO, all for off-label uses. Carter-Wallace continued its astounding second half market ride: from 90-3/4 at the end of the third quarter, the stock climbed another 32-3/8 points to close the year at 123-1/8 (up 130%). The wild upward ride, stimulated in part by the company's NDA application for an anti-epileptic drug (felbamate), may be a fitting last work on the uncontrollable enthusiasm for drug stocks during the year.
Subject: PFIZER's 23% SURGE IN DECEMBER CAPS BIG YEAR; DRUG STOCKS ARE WINNERS ACROSS-THE-BOARD; FUTURE PRICE RESTRAINTS ARE GAINING WALL STREET ATTENTION


text:
GL NPSL Falls in Home Opener to Elm City Express
On May 7th, during intermittent rain showers, GL NPSL and Elm City Express opened up their seasons in Tyngsboro, MA. Each team set their tone early. Elm City's direct style of play provided them with many chances, however, those chances where well dealt with by Lowell's strong defensive core.
Elm City was able to break through early on a breakaway. The attacker broke free into the box where the Lowell goalkeeper came out and took him down, the referee pointed to the spot and a penalty was awarded. The Elm City attacker lined up the kick, struck the ball and missed wide right, leaving the score tied at 0-0.
Elm City continued to attack for the rest of the half, earning five corners and utilizing their long throw whenever possible, overall attempting six shots. This is in comparison to Lowell's one corner earned and one attempted shot, which sailed well over the goal.
Despite Elm City's relentless direct attack, GL NPSL was able to keep the score level at halftime thanks to a strong defensive performance.
An early Lowell turnover led to Elm City's first opportunity of the second half. Anthony Asante, who struck the ball right at the Lowell goalkeeper, Cooper Hall, who was able to make the save.
Moments later Asante found himself running onto goal again. He made a defender miss, but again the Lowell goalkeeper was up to the task coming off of his line to make the save, which was then put out for a corner kick.
Lowell was able to create a few chances as well. The first coming from Quincy Appah who took on a defender and took a shot from just outside the box which just missed the goal sailing over the crossbar. Another came from Alexnder Alleyne, a free kick whipped into the box and claimed by Elm City goalkeeper Matt Jones.
Appah again was able to beat a defender, take a touch into the box and get a shot off, this time striking it right into the arms of the Elm City goalkeeper.
Lowell came out in the second half slightly more offensive-minded and was able to create more chances. However, all of their work was undone with the blow of a whistle. In the 84th minute an Elm City attacker took a shot that struck the arm of Lowell defender Doug Searl inside of the box. The official pointed to the spot and awarded another penalty to Elm City. This time Asante took the opportunity to put it away, giving Elm City a 1-0 lead.
In the 86th minute Asante struck again as Lowell committed numbers forward trying to equalize in the few minutes left in the game. Shaquille Sanchez broke free and found Asante inside the box, who slotted the ball home to give Elm City a 2-0 lead and that is how the game would end.
2017 northeast
ALBION PROS DOMINATE CITY OF ANGELS FC, LOOK TO U.S. OPEN CUP
FC Arizona Defeats SoCal SC 4-0


Do you ever feel like every other couple knows everything about relationships, while you can't even agree on what's for dinner? In this dynamic series, discover the truth about what every couple thinks they know about dating, love, and marriage! Catch up on previous series.
Kids Camp 2019! Kids Camp is for is for kids currently in grades 4th & 5th. Kids Camp will be at Virginia Wesleyan College in Norfolk, VA from July 15-18. Registration opens January 30th. Early Bird rates ends March 31st. Find out more information about Kids Camp here!
Student Camp 2019! Student Camp is for students who are currently in grades 6th-12th. It is a five day experience, July 16 - 20 at Crowders Ridge Camp in Gastonia, NC. Camp Registration opens January 30th. Early Bird rates ends March 31st. Find out more information about Student Camp here!
There is no better time than now to be a part of Waters Edge Church! Click here to check out available positions. If you are interested in applying for a position, read the job description, fill out the questionnaire, and then complete the application.
This month, we honor Bryan Glover from our Williamsburg Campus! He is our WEC volunteer of the month!
You're receiving this because you are a regular attender or have requested to be on our newsletter list.


text:
Sabine Karin Doris Hossenfelder (Frankfurt am Main, 18 september 1976) is een Duits theoretisch natuurkundige. Ze werkt bij het Frankfurt Institute for Advanced Studies aan astrofysica, zwaartekracht, en deeltjesfysica.

Levensloop

OpleidingProefschrift
Hossenfelder deed in 1995 eindexamen aan het Albert-Einstein-Gymnasium in Schwalbach am Taunus.
Vervolgens studeerde ze aan de Goethe-Universiteit in Frankfurt am Main eerst wiskunde (BS, 1997), en daarna natuurkunde; ze studeerde in 2000 af bij Walter Greiner met beoordeling cum laude voor haar eindwerk Particle Production in Time Dependent Gravitational Fields.
In 2003 promoveerde ze bij Horst Stöcker, eveneens cum laude, op het proefschrift Schwarze Löcher in Extra-Dimensionen.

Loopbaan
Ze was achtereenvolgens postdoctorale student aan de GSI Darmstadt (2003-2004), aan de Universiteit van Arizona (2004/2005), aan de Universiteit van Californië in Santa Barbara (2005/2006), en aan het Perimeter Institute te Ontario in Canada (2006-2009).
Van 2009 tot 2015 was ze universitair docent aan het Nordic Institute for Theoretical Physics (Nordita) in Stockholm.
In 2015 werd ze wetenschappelijk medewerker (Research Fellow) aan het Frankfurt Institute for Advanced Studies.

Persoonlijk
Hossenfelder was van 2010 tot 2012 met ouderschapsverlof.

Publicaties

Boeken
Hossenfelder was redacteur van het boek Experimental Search for Quantum Gravity (Springer, 2018).
Het boek vat recente ontwikkelingen samen van de fenomenologie van kwantumzwaartekracht.

In 2018 publiceerde ze een boek getiteld Lost in Math: How Beauty Leads Physics Astray (Basic Books 2018).
In dit boek stelt Hossenfelder dat er stagnatie is in de theoretische fundamentele natuurkunde.
De reden is dat natuurkundigen vinden dat de beste theorieën wiskundig mooi, natuurlijk en elegant horen te zijn, en dat mooie theorieën vanwege hun schoonheid juist moeten zijn, ondanks experimentele resultaten die dat tegenspreken.

Artikelen
Ze heeft tientallen wetenschappelijke artikelen geschreven over de algemene relativiteitstheorie, kwantumzwaartekracht, deeltjesfysica, quantum foundations, en statistische mechanica.

Hossenfelder schrijft ook met regelmaat artikelen over natuurkundig onderzoek buiten de vakbladen. Ze heeft gepubliceerd in o.a. Scientific American, Forbes Magazine, Spektrum der Wissenschaft, New Scientist, Quanta Magazine, Nautilus en Aeon.

Blog
Ze schrijft over wetenschap en haar Youtube-video's in haar blog Backreaction, onder het pseudoniem Bee.
Haar blog wordt omschreven als "een van de bestgelezen in zijn soort door beoefenaren van de theoretische hoge-energiefysica".

Youtube
Voor haar YouTubekanaal Science without the gobbledygook (wetenschap zonder jargon) maakt Hossenfelder Engelstalige video's met uitleg over de moderne natuurkunde, interviews met andere onderzoekers, en ook muziekvideo's.
Ze publiceert de tekst van haar video's op haar blog.
Het aantal abonnees steeg in 2020 tot boven de 100.000.

Opinies en kritiek

Ze wordt als volgt beschreven: "onbevreesd en oneerbiedig",
"ongemeen kritisch",
"niet bang om haar medefysici te grieven", "levendige, ongezouten stijl".

Voordat haar boek Lost in math uitkwam schreef ze dat ze voorzag dat de meesten van haar collega's het zouden verfoeien; bij het schrijven ervan gaf ze de hoop op een vaste aanstelling op.

Bij gebrek aan experimentele gegevens om schoonheidscriteria zoals natuurlijkheid aan te tonen gebruikt men niet-empirische argumenten, die volgens Hossenfelder nooit objectief kunnen zijn en leiden tot cognitieve bias.
Het zoeken naar schoonheid in natuurkundige theorieën is strijdig met wetenschappelijke objectiviteit, en heeft geleid tot theorieën die niet experimenteel getoetst kunnen worden, met name snaartheorie, supersymmetrie.

Haar kritiek richt zich met name op de snaartheorie (volgens Hossenfelder zijn de beoefenaars goedkoop voor de universiteiten) en supersymmetrie, die nog steeds de hoofdstroom van onderzoek zijn, zelfs nadat experimentele bevestiging van "superpartners" en extra dimensies al decennia lang uitblijft.
Ze bekritiseert verklaringen met voornamelijk niet-waarneembare verschijnselen zoals het concept multiversum.
Ze heeft geen problemen met onderzoek op dit gebied, maar wel met beweging in een richting die uiteindelijk geen natuurkunde is.

De talrijke voorspellingen van nieuwe elementaire deeltjes vindt ze typerend en blijk geven van een carrièrebevordering: identificeer een bekend open probleem dat van nature wordt opgelost door een nieuw deeltje te postuleren, voorzien van eigenschappen die verklaren waarom het tot nu toe niet is ontdekt en waarom dat zal in de niet al te verre toekomst mogelijk zijn. Door de eigenschappen aan te passen kan dit moment steeds verder de toekomst in worden geduwd.

De experimentele hoogenergetische fysica staat stil, omdat er al meer dan 40 jaar geen grote doorbraak is geweest ondanks de ontdekking van het Higgs-deeltje in de LHC, vooral met betrekking tot de zoektocht naar donkere materie.
Hossenfelder geeft zelf de voorkeur aan alternatieve verklaringen zoals aanpassingen aan de gravitatietheorie.

Veel theoretische artikelen vindt zij nutteloze speculatie: De meeste theoretische natuurkundigen die ik ken, bestuderen nu dingen die niemand ooit heeft gezien of gemeten.
Ze vreest een verlies van vertrouwen bij het publiek in fundamenteel onderzoek door de vele speculaties die zonder voldoende gegevens in de pers zijn verschenen.

Volgens Hossenfelder is vrije wil een illusie.
Het kan door geen enkele natuurwet worden gerechtvaardigd, aangezien deze ofwel deterministisch zijn (ook in de chaostheorie) met uitzondering van de kwantummechanica, die alleen een oncontroleerbaar toeval kent.

Hossenfelder vindt dat het concept multiversum niet wetenschappelijk is.

Hossenfelder heeft zich kritisch uitgesproken over een (grotere, duurdere) opvolger van de Large Hadron Collider van CERN.
Ze stelt dat de van de LHC verwachte ontdekkingen op gebieden als donkere materie, extra dimensies, kleine zwarte gaten, gravitonen, en nieuwe elementaire deeltjes zoals voorspeld door de theorie van supersymmetrie zijn uitgebleven.
Het enige succes was de ontdekking van het Higgsboson.
Hossenfelder stelt dat er geen voorspellingen zijn die met een grotere versneller kunnen worden getoetst.
Ook zou de nieuwe versneller (kosten: tien miljard euro) ten koste gaan van kleinschaliger en goedkoper onderzoek.

Hossenfelder heeft kritiek op de academische publicatiedruk en stelt dat er sprake is van wijdverbreid kuddegedrag (groepsdenken), een neiging tot overhaaste publicaties en de wens om zo vaak mogelijk te worden geciteerd.
De verplichting om te publiceren stelt de uitgevers niet in staat te wachten op nieuwe kennis, noch stelt het de ontvangers in staat individuele artikelen gericht te lezen (informatiestroom). Hossenfelder pleit voor overgangsbeurzen waarmee wetenschappers interdisciplinaire wetenschappelijke mobiliteit kunnen uitoefenen.

Zij ziet religie als toevlucht voor mensen die niet willen toegeven dat ze ergens geen verklaring voor hebben.

Externe links
 Persoonlijke website
 Youtubekanaal: Science without the gobbledygook
 Hossenfelder's blog

Noten

21e-eeuws natuurkundige
Duits natuurkundige
Duits youtuber
Theoretisch natuurkundige

redpajama_set_name: RedPajamaWikipedia


text:
Watch: Press Sec Kayleigh McEnany Sets The Record Straight On Turncoat 'Republican' Gov Crazy COVID-19 Claims
Turncoat Maryland Gov. Larry Hogan, on Thursday, went after President Donald Trump over his handling of the coronavirus.
Hogan wrote an essay for the Washington Post titled "Fighting Along." Hogan said:
"I'd watched as the president downplayed the outbreak's severity and as the White House failed to issue public warnings, draw up a 50-state strategy, or dispatch medical gear or lifesaving ventilators from the national stockpile to American hospitals," said Hogan, the Republican chairman of the National Governors Association.
"Eventually, it was clear that waiting around for the president to run the nation's response was hopeless; if we delayed any longer, we'd be condemning more of our citizens to suffering and death. So every governor went their own way, which is how the United States ended up with such a patchwork response.
"Governors were being told that we were on our own. It was sink or swim. And if I didn't do something dramatic, we simply would not come close to having enough tests in Maryland," he said.
Hogan claimed that the federal government should have taken control during the pandemic (God forbid he do his job).
"An undertaking as large as a national testing program required Washington's help. We expected something more than constant heckling from the man who was supposed to be our leader," he said.
On Thursday afternoon Press Secretary set the record straight when asked about Gov. Hogan's op-ed. She said that Logan is engaging in "revisionist history" and ran off a series of different quotes from Hogan praising the President just a few weeks ago.
.@PressSec slams Gov. Larry Hogan for his 'revisionist history' in his recent comments. pic.twitter.com/6h5E8S4eCK
— Benny (@bennyjohnson) July 16, 2020
What's suspicious is that Hogan was spouting off Democrat talking points claiming that the President cares more about the stock market than Americans.
"Meanwhile, instead of listening to his own public health experts, the president was talking and tweeting like a man more concerned about boosting the stock market or his reelection plans," he said.
Seems like Maryland's governor just got a new nickname, Benedict Hogan and he's running to MSNBC like a lap dog.
Written by	Staff Writer - July 16, 2020


Equipped with everything guests may require for a relaxing stay.
Parow forms part of Cape Town's Northern Suburbs, it lies east of Goodwood, and south west of Bellville. This suburb is situated very close to Cape Town's CBD, via the N1 and N7, which is why many residents choose to stay here. If you are visiting this interesting suburb any time soon, for leisure or a holiday, be sure to check out these options for budget or luxury accommodation in Parow. When staying in Parow, you have a whole bunch of activities around you. From this area, you have access to a wide range of shopping options, whether you are seeking bargains or fashion brands. Canal Walk, Tygervalley, and Willowbridge are all within close reach of Parow. If you are not one for shopping, there are always all the wine routes surrounding this area. Visitors have the option to go to the Durbanville or Constantia Wine Route from here, since both are close by. When choosing this option, guests will be able to enjoy a day filled with world-class wines and delicious foods, not to mention the stunning landscapes. Whatever you choose to do with your time in the Cape, it is important that you have a comfortable place to rest your head. For accommodation in Parow that will not break the bank, feel free to go through the options below.


Good sized three-handled silver bowl or tazza made by Horace Woodward & Co Ltd who had workshops in both Birmingham and London between 1893 and 1916.
With delighfully elegant lines, the three handles sweeping outwards and up from a circular tapering base, rising above the bowl before curving downwards and dividing into two at the point where they join the rim.
Showing a London hallmark for the year 1908, and with a height to the top of the handles of 21 cm. The internal diameter of the bowl at the rim is 20 cm.


Fitted with the amazing Evertune® bridge, the TraXe Jazz only needs to be tuned when you change the strings!
With A 24 inch scale maple neck and a 20 fret Maple fingerboard, this guitar is comfortable and easy to play and a zero fret makes intonation easy.
The Jazz may have taken inspiration from a certain style, but a pair of mini humbuckers with coil tap offer a wide range of tones. From warm thump in the neck position to bite and snarl in the bridge, this guitar sounds great whatever your preference.
Our most stable and versatile guitar to date. The TraXe Jazz Noir is perfect for anyone looking for a portable tool for live and studio use.
Push pull volume control - for coil tap selection .


Meet in our newly renovated showroom and meeting space. Plan your perfect day with our team of professionals to ensure none of your important moments are missed.
Our staff will execute your vision frame by frame on your big day. Using state of the art equipment, we'll make sure your wedding is documented in the most cinematic way possible.
Your wedding day will be pieced together frame by frame. Your vision will be executed in order to achieve your desired look and feel. Our state of the art software will ensure that your footage will be delivered in the cleanest possible way.
Your footage will come in a high-definition format on a USB drive. Other formats are available upon request. All highlight reels are posted on a high definition, ad-free video player shareable on all social media platforms.


RD-Monoguard, High Performance coating formulated with a mix of new generation acrylic resins and innovative anti-corrosion additives.
High performance coating combining waterproofing and anti-corrosion properties. Waterborne elastomeric paint used as primer and top coat.
Since 2001, RD Coatings is the technical coating range of Dothée S.A.
RD Coatings is the professional range of technical coatings produced by Dothée S.A., a Belgian paint manufacturer active since 1946.
It specializes in the research and development of high performance waterborne coatings for the protection of the building envelope, commercial and industrial facilities, and infrastructures.
RD Coatings consists in a range of High Performance protective coatings, 100% Waterborne, offering solutions for Anti-corrosion, Liquid Waterproofing, Anti-carbonation and Wear Resistance.
RD Coatings offers a range of coatings which is 100% waterborne. It's safer for the applicator, safer to transport, safer to store and better for the environment.
Most RD Coatings products are single pack and ready for use. We develop our coatings as single product solutions, allowing an easier approach on the project with greater benefits for the specifying bodies, the applicators and the owner.
High quality of the raw materials we use, high expertise of our r&d team, long tradition in the manufacturing of technical coatings makes our coatings highly durable and offers higher project productivity.


text:
01/16/22 - 34 New Stories - REAL Environmental & Conservation Leadership In PA: http://bit.ly/3qxhMy7
Tweets by @paenvirodigest
House Considers Amendments to Governor's $850 Million Energy Plan
Rep. DePasquale
The House in Special Energy Session considered amendments to Special Session House Bill 1 (DePasquale-D-York) that establishes Gov. Rendell's $850 million bond-funded Energy Independence Plan to support clean and renewable energy resources and energy conservation programs.
The bill would allocate $850 million in bond funding to the Pennsylvania Energy Development Authority and the Commonwealth Financing Agency to support research, development and deployment of various alternative energy projects and technologies.
Proposals include creating a rebate program for the purchase of energy-efficient appliances and establishing a rebate and grant program for the use of solar energy. In addition, a percentage of the funding would provide grants and loans for alternative energy projects, alternative fuels, demand-side management and energy-efficient measures.
"We are in a position to become a leader in alternative energy production and we need to continue to think outside the box and provide incentives that will encourage industries and consumers to be more energy efficient, while bringing new economic development opportunities to our region," Rep. Eugene DePasquale said.
"Investing in alternative energy and moving away from our dependence on Middle East oil will provide us with an opportunity to create jobs, protect our environment and national security interests, and strengthen the energy industry all while adding cost savings for consumers," Rep. DePasquale said. "I am excited to move forward with this initiative and provide the Senate with a comprehensive and detailed approach to making Pennsylvania a national leader in alternative energy production."
The House added amendments to the bill that would provide a set aside of $30 million to support the development of wind energy facilities, $5 million for the Keystone Home Energy Conservation Program, $25 million to promote the development of high performance green buildings and the use of up to $25 million to install pollution control equipment for small coal-fired power plants.
"Yesterday, our state lawmakers said 'yes' to good-paying jobs in the utility industry," said Paul Bachman, President of The Central PA Building Trades. "Environmental Resources and Energy Committee Chairman Bud George deserves special recognition for his efforts at building a bipartisan majority in the House of Representatives."
"Today, the House took an important step towards protecting Pennsylvania jobs, Pennsylvania coal and Pennsylvania power producers," said George Ellis, President of the PA Coal Association. "This bipartisan show of support tells us that our lawmakers are serious about including clean coal technologies in our long term energy independence strategy."
The House defeated an amendment that would have earmarked $25 million a year for 10 years from the State Store Fund to support the programs, rather than financing an $850 million bond.
The bill will be in position for a final vote the week of March 10 when the House returns to Special Energy Session.
NewsClip: House Prepares Green Energy Bill for Final Vote
House Adds More to Green Energy Bill
Going Green Is Going to Cost a Lot of Green
Go To Preceding Article Go To Next Article
Return to This PA Environment Digest's Main Page
Follow @paenvirodigest
PA Environment Digest
PaEnviroDigest@gmail.com
PA Environment News LLC


Cindy Aldridge offers her "10 Holiday Gifts Your Fur Baby Will Love" this Christmas. Ideas range from winter coats to ball launchers. Send us your favorite gift ideas at contact@straymagnet.com. Happy Holidays!


text:
Approximately 130 million nonelderly people have pre-existing conditions nationwide, and, as shown in the table available below, there is an average of more than 300,000 per congressional district. Nationally, the most common pre-existing conditions were high blood pressure (44 million people), behavioral health disorders (45 million people), high cholesterol (44 million people), asthma and chronic lung disease (34 million people), and osteoarthritis and other joint disorders (34 million people).
While people with Medicaid or employer-based plans would remain covered regardless of medical history, the repeal of pre-ex protections means that the millions with pre-existing conditions would face higher rates if they ever needed individual market coverage. The return of pre-ex discrimination would hurt older Americans the most. As noted earlier, while about 51 percent of the nonelderly population had at least one pre-existing condition in 2014, according to the HHS brief, the rate was 75 percent of those ages 45 to 54 and 84 percent among those ages 55 to 64. But even millions of younger people, including 1 in 4 children, would be affected by eliminating this protection.
Jettisoning pre-existing condition protections would undermine the fundamental purpose of health insurance, including providing both the healthy and sick access to care and protecting families from financial ruin. Medical history should not be a barrier to affordable coverage.
How will you be affected by changes in the current healthcare laws? You decided! Below are links to each perspective. Write your Congress Representatives!
Affordable Healthcare Act (ObamaCare)
American Healthcare Act (AHA)


text:
Stacey Dimas (right) and her fiancé watch her son's football game at Ithaca High School. (Ryan Young / Cornell University)
Working to Reunite Families Fractured by Opioids
Stories You May Like
We Met as Freshmen—and Climbed Kilimanjaro Together at Age 70
On 'Undercover Boss,' a Hotelie Gets His Hands Dirty—Literally
Meet the Overtons—A Big Red Family for Six Generations
How Cornell researchers and Cooperative Extension staff—plus an alum who's a Tompkins County judge—are making a difference
This story has been condensed from a feature in the Cornell Chronicle.
By Susan Kelley
When her opioid addiction was at its worst, Stacey Dimas was terrified her sons, 3 and 10, would find her dead from an overdose in the family bathroom. She wrote them each a letter with life advice in case they had to carry on without her.
"There's an extra layer, when you're using, of incomprehensible demoralization—those are the only words I have to describe it," Dimas says. "I hated what I saw in the mirror. I didn't think I was a good parent. In fact, I knew I wasn't a good parent. And obviously the courts agreed with me."
Dimas lost custody of her kids in 2015, after her mother and mother-in-law reported her to Child Protective Services for neglect. The boys went to live with her in-laws.
Dimas was referred to Tompkins County Family Treatment Court—whose founding judge is Arts & Sciences alumnus John Rowley '82.
Judge Rowley in court in Ithaca.
Dimas and her children are among the hundreds of thousands of New Yorkers whose lives have been ravaged by opioid abuse. The epidemic spurred Cornell researchers and parent educators to analyze the opioid crisis's impact on families and assess the efficacy of solutions to treat parents who misuse opioids.
In traditional child welfare courts, parents take longer to start substance abuse treatment, return to drug abuse more quickly, and are less likely to reunite with their children. Tompkins County Family Court, which incorporates Cornell programming, follows a therapeutic approach to family reunification.
The Tompkins County collaboration inspired an ambitious five-year research program, the Opioids and Family Life Project, launched by Cornell researchers in 2018.
The team is evaluating how the court's use of a parenting class called Strengthening Families, run by Cornell Cooperative Extension (CCE) Tompkins County, helps strengthen and reunify families fractured by opioids by teaching them skills from solving problems to coping with anger.
With CCE's data-informed guidance at its core, the Tompkins County Family Court has become a model for New York State and the nation.
Since 2018, the court has been one of eight peer-learning courts around the country, offering guidance to other family treatment courts from West Virginia to Guam, through a program run by Children and Family Futures, a child-welfare nonprofit.
"As a society, we haven't thought a lot about what it means to be a parent who's struggling with opioid addiction and what supports are needed for parents to be able to thrive in that role," says Rachel Dunifon, the Rebecca Q. and James C. Morgan Dean of the College of Human Ecology (CHE) and a co-principal investigator on the project, along with Anna Steinkraus of CCE Tompkins County.
"We can't look at parents in isolation and look at the kids in isolation. We have to think about them together, and what they need as a family."
As a society, we haven't thought a lot about what it means to be a parent who's struggling with opioid addiction.
Rachel Dunifon, dean of Human Ecology
In 2017, opioids were hitting families hard in Tompkins County, says Steinkraus, who coordinates CCE's parenting programs in the county.
"They were being drawn into social services, generally more around [child] neglect, because their involvement with opioid use was making it hard to be focused on parenting," she says.
The Opioids and Family Life Project, housed in CHE's Bronfenbrenner Center for Translational Research, represents a new model of research because it was created collaboratively with the CCE Tompkins County team, Dunifon says.
Dimas in Ithaca's Dewitt Park.
"Their on-the-ground experiences allowed us to conduct really important groundbreaking scientific research that's based on what's happening in our community," she says.
"It makes the work we do more relevant, more nuanced, and more impactful toward our ultimate goal, which is improving the lives of people in our local community, in New York State, and around the world."
The researchers have found opioids affect one in 12 New Yorkers, or more than 8%, directly or indirectly, through their immediate family members. They also found that since 2010, over a 10-year period, the rate of both opioid misuse and family members being affected increased by more than 100%.
And they've identified an association between rising rates of opioid misuse and child maltreatment in New York State. From 2006–16 those rates were geographically concentrated in Western and Central New York, the Finger Lakes region, and the Southern Tier, which includes Tompkins County and Cornell's Ithaca campus.
A court focused on drug treatment
The opioid epidemic is the main reason the number of cases in the county's Family Treatment Court has more than doubled, from 30 in 2001 (when the court was created) to 75 so far in 2022, says Rowley.
About 75% of neglect cases involve substance abuse, most often opioids; parents frequently start out misusing prescription drugs and then switch to heroin because it is cheaper, he says.
"What we're most concerned about is … it's a complete disconnect from your environment," Rowley says of opioids' effects. Parents who misuse opioids "are not generally functioning in any significant way. Certainly, the emotional engagement is impaired."
The biggest effect? "Their addiction becomes their primary relationship," he says. "And that means everything else is secondary"—including their children.
Their addiction becomes their primary relationship. And that means everything else is secondary.
Judge John Rowley '82
Parents who misuse opioids might drop off their children with someone and fail to come back when they said they would, Rowley says. They're unable to get their kids to school. They don't give their children enough food or emotional support.
Sometimes they use harsh discipline. Older children may take care of siblings in their parents' absence or take on household chores beyond their capacity.
Parents often think their kids are unaware of their opioid misuse. But children do know, Rowley says. "[They'll say] 'I could tell Mom was talking fast.' 'Mom was in the bathroom for a really long time.' 'Dad really tried to hurry us through dinner. Whenever he tries to put us to bed fast, we know something's going on.'"
CCE programming "is an extremely important resource to us," Rowley says. "It's because these evidence-based programs, they actually work. Our parents experience it, we experience it. So we just keep building on that."
Rowley with a colleague in his chambers.
When Dimas started Family Treatment Court, she was living out of her car, had no friends, no family. She and her husband had split up.
"They say addiction is a disease of isolation," Dimas says. "And I absolutely believe that to be true … The only things I had, when I left detox for the second time, were the clothes that I took to detox and the blanket that I stole."
Dimas was reunited with her children in 2016. She and her husband divorced. She has been sober for more than seven years, since February 2015. And she mentors others in recovery.
Today, she is employed as senior adviser for People for the American Way, a progressive advocacy organization, where she focuses on reimagining public safety. She is engaged to be remarried. She has a bachelor's degree.
"People always ask, 'How did you do it?'" she says. "I realized I needed help. And I asked for it. And lastly, I accepted it."
Top: Stacey Dimas (right) and her fiancé watch her son's football game at Ithaca High School. All photos and video by Ryan Young / Cornell University.
Once your comment is approved, your email address will not be published. Required fields are marked *
Save my name, email, and class year in this browser for the next time I comment.
Other stories You may like
Cornellian Crossword: 'School Spirit'
New Hotel at Cornell Tech Boasts Breathtaking Views and Big Red Touches


Issue #1 shipped this week and it is a joy to behold. The first issue features ten pages of Gasoline Alley, six of Alley Oop, four of Tarzan, four of Bronc Peeler, four of Stumble Inn, two of Wee Willie Winkie's World, and one of Crazy Quilt.
GASOLINE ALLEY: The current "Walt and Skeezix" series (volume five of which shipped recently and covers 1929-1930) reprints dailies only. There was a single volume of color Sundays released a couple of years ago, but it is not comprehensive. Frank King is known equally for his innovative Sunday layout and design as he is for his ongoing narrative in which the characters age in real time. The earliest strips are printed in duo-tone red and white, but full color was added after a while. This is easily my favorite feature.
ALLEY OOP: There isn't a comprehensive collection of Alley Oop dailies or Sundays. My second favorite feature.
TARZAN: The story picks up about a year into Hal Foster's run. I already have a complete collection of Foster's and Hogarth's Tarzan in hardcover, but these Sundays are HUGE!
BRONC PEELER: I've seen little of this strip prior to this publication. One of my comic strip anthologies (the Smithsonian collection, I think…?) reprints the episode in which the titular cowboy must shoot his horse, so perhaps some of you reading this have seen it, too. The narrative is supplemented by a portrait in the center of the page along with the poem "Nothin' but a Hoss." The strip itself is drawn in a somewhat humorous style, but the portrait (by the same artist) looks almost like a fine water-color painting. Evidently, this format (narrative with a portrait in the middle) was a staple of the strip, because all four examples feature it.
STUMBLE INN: By George Herriman (better known for Krazy Kat), a thematic precursor to Berke Breathed's Bloom County (the early days, anyway). Herriman must have been an influence on Breathed, because certain aspects of later Bloom Country, and especially its follow-up, Outland, greatly resembled Krazy Kat.
WEE WILLIE WINKIE'S WORLD: An experimental strip in which inanimate objects are imbued with life via a child's imagination.
CRAZY QUILT: Features highly innovative layout, the front page of issue one.
These strips are reprinted in the original size, a Sunday broadsheet, which is (as I mentioned above) HUGE! The paper stock is thick, non-glossy and brilliantly white, beautifully showcasing the original colors (as well as the slight yellowing of the source paper). Each issue consists of three sections, which are available separately (@ $10) or bagged together ($30).
The second page (inside front cover) is reserved for editorial material, the majority of this issue presenting an overview of the life of the founder and director of the San Francisco Academy of Comic Art, Bill Blackbeard. I have known of Blackbeard for many years, but after reading this article, my respect and admiration knows no bounds.
Editor Russ Cochran also provides his e-mail address for feedback regarding future features.
Issue #2 shipped last week, and as much as I liked the first issue, the second is even better. It has switched to a somewhat thinner, cream-colored (rather than stark white) paper stock which allows for better color saturation. Two new features have been added: Connie and Buck Rogers in the 25th Century.
BUCK ROGERS: Like many of its contemporaries, the Sunday page featured a continuity wholly separate from the dailies, but unique (as far as I know) in this case because it doesn't feature Buck Rogers at all, but rather Wilma Deering's little brother, Buddy. Hermes Press will be releasing a second collection of these strips on Wednesday, but the presentation (colors, paper stock and SIZE) is superior in Sunday Funnies. The strips run from the beginning.
CONNIE: I was unfamiliar with this action/adventure strip, but it's very exciting. The story picks up in medias res, but will sweep you up into it so quickly and completely you will hardly notice.
Regular ongoing features have been announced as being GASOLINE ALLEY, ALLEY OOP, CONNIE and TARZAN.
Remember how much discussion there was of DC's Wednesday Comics a couple of years ago and how much discussion there was of it? It was a noble experiment to recreate the excitement of the past, but here's the real thing, baby! Everyone who read and enjoyed Wednesday Funnies should be reading Sunday Funnies.
I think Connie started as a humour strip and became an adventure one. SF sequences appeared in the dailies as well as the Sundays. (Minor Spoilers.) I've seen part of a daily sequence in which she took part in an expedition into space that toured the solar system, encountering monsters and at least one alien civilisation. On returning to Earth she got involved with a hidden city that had been established in the Arctic. Doesn't she travel into the future in the Sunday story?
This post displaced the thread 'Star Trek: The Next Generation' by Brannon Braga comes to IDW from the Sneak Peeks, Solicitations & PR from the home page.
The Digital Comic Museum, in its "Classic Newspaper Comic Strips" section, has a collection of Godwin's Vignettes of Life pages from the later 20s, which satirised aspects of modern life.
This page displaced the thread Movies I Have Seen Lately from the home page.


Quad Business Park is offering a rare opportunity to secure a small office space in Sydney Olympic Park.
Suites are being offered to tenants with brand new fitouts making it the perfect space for small businesses to set up with minimal expenditure making these opportunities high cost effective.
"It is not very often you see smaller sized suites with brand new fitout available in locations like Sydney Olympic Park" Mr Bailey said.
Quads 2 & 3 are set back from the main thoroughfare which ensures a sense of tranquillity, yet it is still within a short walking distance of all the unique amenity of Sydney Olympic Park. Surrounding amenities include a wide range of cafes, bars, fast food and restaurant options. Retail and services options are available from banks to convenience stores, everything you need is just minutes away.
Sydney Olympic Park is known for its perfect combination of business and lifestyle.


Mrs. Francis Quick McClellan "Frankie", 82, of Waynesboro, went home to be with her Lord and Savior Saturday, June 20, 2015. She was born in Vidette, Ga. on June 24, 1932 to the late R. Lloyd Quick and Pearle Aaron Quick and has lived all her life in this area. She was a member of the First Presbyterian Church of Waynesboro. Frankie worked for many years at John L. Fulcher CPA. She will always be remembered as a loving wife, mother, and "Nan," as she was affectionately known by her grandchildren. In addition to her parents, she was preceded in death by her husband, Donald McClellan, Sr.
She is survived by four children, Dean M. Hall of Waynesboro, Donna M "Cissy" LaRoche (Frank) of Brunswick, Ga., Diane M. Quick of Waynesboro, and Don McClellan Jr. (Michele) of New Orleans, La.; one sister, Bobbye Q. Cobb of Millen; thirteen grandchildren, Michael Penrow (Tammy) of Kansas City, KS, Brian Penrow of Waynesboro, Amanda Hendley (Billy) of Waynesboro, Dawn McDaniel (Garrett) of Alexander, Matthew Reeves of Waynesboro, Toby Quick (Heather) of Waynesboro, Brandon Quick of Waynesboro, Donald McClellan III of Hazlehurst, Ga., Scott McClellan of Hazlehurst, Ga., Cullen McClellan of Athens, GA, Madison McClellan of New Orleans, La., Mollie Shoemaker of New Orleans, La., and Randall Shoemaker of New Orleans, La.; seven great -grandchildren; one great-great -grandchild; several nieces and nephews; and many other family members.
The family received friends from 5-7pm Monday, June 22 at the funeral home. Graveside Services were held at 10 a.m. Tuesday, June 23 at Magnolia Cemetery with Rev. Logan Almy officiating. Pallbearers were Michael Penrow, Brian Penrow, Toby Quick, Brandon Quick, Matthew Reeves, Steve Penrow, and Lee Fulcher.


text:
San Juan County Democrats owe state $8K for finance disclosure infraction
By Hayley Day • May 21, 2018 12:58 pm
The San Juan County Democratic Party committee has agreed to pay a penalty for failing to report contributions and debts in 2016.
The lawsuit, filed by the Washington State Attorney General Office last summer, was settled on April 20 in the Thurston County Superior Court.
The San Juan County Democrats agreed to pay nearly $8,000 for failing to report contributions and debts in 2016, as well as nearly $5,000 for attorney, court and investigation fees.
If the party does not follow state laws on campaign disclosure and contributions over the next four years, members will also be obligated to pay about $4,000 within 30 days of finding the infraction.
According to court documents, San Juan County Democrats is a political party, registered in Washington state.
A press release by the state Attorney General's Office states that staff filed a complaint on the party last June because "the committee failed to timely report a total of $30,290 in expenditures, $15,514 in debt and $15,060 in contributions throughout 2016."
The Attorney General's Office was notified of the infraction by a citizen.
Glen Morgan, who runs a website about Washington state called www.wethegoverned.com, attests to making the initial complaint last April in a post on the site.
The website states that Morgan has filed nearly 400 public disclosure campaign finance complaints in the state, from 2016-18, which "have resulted in over 50 lawsuits against state legislators, state senators, county Democratic Party committees, judges, and other politicians who violated the Washington State's campaign finance laws."
According to www.wethegoverned.com, Morgan is the executive director of the Citizens Alliance for Property Rights and worked at the Freedom Foundation from 2011-15.
For more info, visit www.wethegoverned.com.
Legion Memorial Day events
Friday Harbor softball heads to state
San Juan School board starts...
By Hayley Day
Friday Harbor High School students...
Reporter praises San Juans safety...
San Juan County District Court...
San Juan Island School District is on a mission, and they want voters to understand why.
By Sienna Boucher • January 28, 2022 1:30 am
EMS works to renew levy in upcoming election
With the EMS Fire merger in the rearview mirror, San Juan Island EMS is now prioritizing campaigning for the renewal…
Fiber arts emerge as fine art at Artists' Registry Show
Fiber arts (aka textile arts) have been a diverse and dynamic method of artmaking and storytelling for centuries. The San…


Lloyd Flanders Oxford collection is designed with comfort in mind. Featuring plush box cushions, supremely wide seating, soft rolling arms, and custom bun feet. This beautifully woven wicker offers an ideal blend of supreme durability and unsurpassed elegance. Adding to the distinctive allure of the Oxford collection is its intricate mini-random weave that creates a delicate appearance that is pleasing to the eye.


Coomera is a suburb of the Gold Coast, in Queensland. It is situated next to the M1 Pacific Highway to the east and bordered by the beautiful Coomera River.
The neighbouring suburb of Upper Coomera is located on the western side of the highway in the Hinterlands.
A fast growing satellite city, Coomera is destined for some major development in future years, with a master-plan underway it is set for a large shopping centre, TAFE and more residential estates on Coomera River. A gateway to Brisbane and the Gold Coast, and situated on the major rail line between the two cities, it is has become prime real estate for investors.


Buckberry Beckons exhale and unwind book now. During America's Gilded Age, titans of industry and commerce, along with society's elite, escaped to the serenity and simplicity of the Adirondack Great Camps.
The staff members (from the ladies at the front desk to the maintenance man) at The Lodge at Buckberry Creek were absolute angels. They helped us SO much and tried to make our stay wonderful even though we were living a nightmare with the car -- and they succeeded.
Book The Lodge at Buckberry Creek, Gatlinburg on TripAdvisor: See 1,149 traveler reviews, 671 candid photos, and great deals for The Lodge at Buckberry Creek, ranked #3 of 73 hotels in Gatlinburg and rated 4.5 of 5 at TripAdvisor.
See contact information and details about The Lodge at Buckberry Creek.
The Lodge at Buckberry Creek was a lovely quiet haven from the horrors of gatlinburg and pigeon forge. It's super close to the national park, the rooms are big & comfortable.
The Restaurant at Buckberry Creek, Restaurants business in Gatlinburg. See up-to-date pricelists and view recent announcements for this location.


text:
Q: Enable SSL in PHP fsockopen() I am using PHP fsockopen() to finalize a payment between my server and PayPal. However, when I try to use an SSL connection, I get this error:
Warning: fsockopen() [function.fsockopen]: unable to connect to ssl://:443
(Unable to find the socket transport "ssl" - did you forget to enable
it when you configured PHP?)

I am sure that my call to the fsockopen() method is correct, as it worked correctly before I upgraded PHP on my development server.
It is important that this connection is encrypted, so I can't work around this.
I can't find any config about fsockopen() SSL connections in my php.ini file. Could anyone direct me to it?
Thank you for your help,
spryno724

A: It means that either your SSL module wasn't compiled with the rest of the PHP or it was compiled but its not enabled via the php.ini ..
Starting point: see what phpinfo() says about ssl ?

A: What OS are you using?  If a *nix platform, PHP was likely compiled without SSL support.  If its Windows, I'd check to make sure the SSL module is enabled in php.ini

redpajama_set_name: RedPajamaStackExchange


A fat man and a skinny man were arguing about who was the more polite. The skinny man said he was more polite because he always tipped his hat to ladies. But the fat man knew he wa开封正规的癫痫病医院有哪些s more courteous because, whenever he got up and offered his seat, two ladies could sit down.
A year later,癫痫到底能不能治好 all young men in the country were drafted to join a war. Most young men who fought died on the battlefield. Luckily, his son avoided entering the war because of his broken leg.